Infinium Global Research Ventricular Assist Device Market | Page 3

controller and power sources worn outside the body. Ventricular assist devices are used in those patients who
are suffering with class III and class IV advanced heart diseases as per New York Heart Association (NYHA) and
patients who are waiting for not suitable for heart transplantation.
Market Insights
Some of the key driving factors attributing to the growth of this include increasing number of patients with
cardiovascular diseases such as hypertension, heart failures and coronary artery diseases, and shortage of
number of heart donors. In addition, changing lifestyle, alcohol consumption, growing obesity and smoking
further were propelling the market growth, as these factors increase the bold glucose and lipid levels, which
results in serious cardiovascular diseases. According to American Heart Association publication, it has been
estimated that in the US alone approximately 5.5 million people suffered from heart failure in 2013 and
300,000 die each year because of heart failure. However, there are certain restraining factors which could
hamper the growth of the market, which includes, high costs associated with the ventricular assist device
implantation compared to other therapies available for CVD diseases and other serious complications such as
severe bleeding, Immunosuppression, etc.
Segment Covered
The report on global ventricular assist device market covers segments such as, type of indication and
application. On the basis of type of indication the global ventricular assist device market is categorized into left
ventricular assist device (LVAD), right ventricular assist device (RVAD) and bi-ventricular assist device (BI-VAD).
On the basis of application the global ventricular assist device market is categorized into BTT therapy & BTD
therapy, destination therapy and BTR therapy.
Infinium Global Research